The Vaccines (21+)
Schedule
Mon Feb 03 2025 at 04:00 am to 06:00 am
UTC-08:00Location
Wonder Ballroom | Portland, OR
Advertisement
CAPVAXIVE (V116) is specifically designed for adults and covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults 50 years of age and older Across four Phase 3 studies, CAPVAXIVE demonstrated robust immune responses in both vaccine-naïve and vaccine-experienced adult populations Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for: Active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B in individuals 18 years of age and older; Active immunization for the prevention of pneumonia caused by S. pneumoniae serotypes 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15C, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B in individuals 18 years of age and📍 Venue: Wonder Ballroom
🏠 Address: 128 Northeast Russell Street
🗺️ Extended Address: Portland, OR 97212
🌆 City: Portland
📍 Location: 45.5408, -122.663Error occurred: DateTime::__construct(): Failed to parse time string (Wonder Ballroom) at position 0 (W): The timezone could not be found in the database
Advertisement
Where is it happening?
Wonder Ballroom, 128 Northeast Russell Street, Portland, OR 97212, US, United StatesEvent Location & Nearby Stays:
